Macter International Limited (PSX:MACTER)
241.61
+2.93 (1.23%)
At close: Sep 17, 2026
Macter International Market Cap
Macter International has a market cap or net worth of 11.07 billion as of September 17, 2026. Its market cap has decreased by -39.41% in one year.
Market Cap
11.07B
Enterprise Value
12.30B
Revenue
11.95B
Ranking
n/a
PE Ratio
13.57
Stock Price
241.61
ChartMarket Cap Chart
Since September 25, 2017, Macter International's market cap has increased from 3.37B to 11.07B, an increase of 228.50%. That is a compound annual growth rate of 14.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 11.07B | -27.21% |
| Dec 31, 2025 | 15.21B | 3.23% |
| Dec 31, 2024 | 14.73B | 265.38% |
| Dec 21, 2023 | 4.03B | -11.96% |
| Dec 28, 2022 | 4.58B | -9.14% |
| Dec 30, 2021 | 5.04B | -15.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 99.15B |
| Abbott Laboratories (Pakistan) | 89.20B |
| Highnoon Laboratories | 48.22B |
| The Searle Company | 45.28B |
| AGP Limited | 41.85B |
| Citi Pharma | 16.36B |
| Ferozsons Laboratories | 13.85B |
| Otsuka Pakistan | 4.11B |